Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer

Clinical Cancer Research

Volumn 4, Issue 4, 1998, Pages 963-971

  Ricciardelli, Carmela ^a   Mayne, Keiko ^a   Sykes, Pamela J ^a   Raymond, Wendy A ^a   McCaul, Kieran ^b   Marshall, Villis R ^a   Horsfall, David J ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b South Australian Health Commission   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHONDROITIN SULFATE; DECORIN; GLYCOSAMINOGLYCAN; PROSTATE SPECIFIC ANTIGEN; PROTEOCHONDROITIN SULFATE; VERSICAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VERSICANS;

EID: 0031921540     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ricciardelli, C., Mayne, K., Sykes, P. J., Raymond, W. A., Tilley, W. D., McCaul, K., Skinner, J. M. S., and Horsfall, D. J. Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early stage prostate cancer. Clin. Cancer Res., 3: 983-992, 1997.
2. Brittis, P. A., Canning, D. R., and Silver, J. Chondroitin sulfate as a regulator of neuronal patterning in the retina. Science (Washington DC), 255: 733-736, 1992.
3. Hardingham, T. E., and Fosang, A. J. Proteoglycans. Many forms and many functions. FASEB J., 6: 861-870, 1992.
4. Caterson, B., Mahmoodian, F., Sorrell, J. M., Hardingham, T. E., Bayliss, M. T., Carney, S. L., Ratcliffe, A., and Muir, H. Modulation of native chondroitin sulfate structure in tissue development and disease. J. Cell Sci., 97: 411-417, 1990.
5. Adany, R., Heimer, R., Caterson, B., Sorrell, J. M., and Iozzo, R. V. Altered expression of chondroitin sulfate proteoglycan in the stroma of colon cancer. J. Biol. Chem., 265: 11389-11396, 1990.
6. Hauptmann, S., Zardi, L., Siri, A., Carnemolla, B., Borsi, L., Castellucci, M., Klosterhalfen, B., Hartung, P., Weis, J., Stocker, G., Haubeck, H-D., and Kirkpatrick, C. J. Extracellular matrix proteins in colorectal carcinomas. Lab. Invest., 73: 172-182, 1995.
7. Yamagata, M., Suzuki, S., Akiyama, S. K., Yamada, K. M., and Kimata, K. Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates. J. Biol. Chem., 264: 8012-8018, 1989.
8. Yamagata, M., Saga, S., Kato, M., Bernfield, M., and Kimata, K. Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts; implications for their roles in cell-substratum adhesion. J. Cell Sci., 106: 55-65, 1993.
9. Yamagata, M., and Kimata, K. Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG M/versican. J. Cell Sci., 107: 2581-2590, 1994.
10. Ernst, H., Zanin, M. K. B., Everman, D., and Huffman, S. Receptor-mediated adhesive and anti-adhesive functions of chondroitin sulfate proteoglycan preparations from embryonic chicken brain. J. Cell Sci., 108: 3807-3816, 1995.
11. Braunewell, K-H., Pesheva, P., McCarthy, J. B., Furcht, L. T., Schmitz, B., and Schachner, M. Functional involvement of sciatic nerve-derived versican- and decorin-like molecules and other chondroitin sulphate proteoglycans in ECM-mediated cell adhesion and neurite outgrowth. Eur. J Neurosci., 7: 805-814, 1995.
12. Perris, R., Perissinotto, D., Pettway, Z., Bronner-fraser, M., Mörgelin, M., and Kimata, K. Inhibitory effects of PG-H/aggrecan and PG-M/versican on avian neural crest cell migration. FASEB J., 10: 293-301, 1996.
13. Bode-Lesniewska, B., Dours-Zimmermann, M. T., Odermatt, B. F., Briner, J., Heitz, P. U., and Zimmermann, D. R. Distribution of the large aggregating proteoglycan versican in adult human tissues. J. Histochem. Cytochem., 44: 303-312, 1996.
14. Scholzen, T., Solursh, M., Suzuki, S., Reiter, R., Morgan, J. L., Buchberg, A. M., Siracusa, L. D., and Iozzo, R. V. The murine decorin: complete cDNA cloning, genomic organization, chromosomal assignment, and expression during organogenesis and tissue differentiation. J. Biol. Chem., 269: 28270-28281, 1994.
15. LeBaron, R. G., Zimmermann, D. R., and Ruoslahti, E. Hyaluronate binding properties of versican. J. Biol. Chem., 267: 10003-10010, 1992.
16. Knudson, C. B., and Knudson, W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J., 7: 1233-1241, 1993.
17. Krusius, T., Gehlsen, K. R., and Ruoslahti, E. A fibroblast chondroitin sulfate proteoglycan core protein contains lectin-like and growth factor-like sequences. J. Biol. Chem., 262: 13120-13125, 1987.
18. Shinomura, T., Zako, M., Ito, K., Ujita, M., and Kimata, K. The gene structure and organization of mouse PG-M, a large chondoitin sulfate proteoglycan: genomic background for the generation of multiple PG-M transcripts. J. Biol. Chem., 270: 10328-10333, 1995.
19. Zako, M., Shinomura, T., Ujita, M., Ito, K., and Kimata, K. Expression of PG-M (V3), an alternatively sliced form of PG-M without a chondroitin sulfate attachment region in mouse and human tissues. J. Biol. Chem., 270: 3914-3918, 1995.
20. Perides, G., Asher, R. A., Lark, M. W., Lane, W. S., Robinson, R. A., and Bignam, A. Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican? Biochem. J., 312: 377-384, 1995.
21. Ruoslahti, E. Proteoglycans in cell regulation. J. Biol. Chem., 264: 13369-13372, 1989.
22. Hausser, H., Groning, A., Hasilik, A., Schonherr, E., and Kresse, H. Selective inactivity of TGF-β/decorin complexes. FEBS Lett., 353: 243-245, 1994.
23. Iozzo, R. V. Tumor stroma as a regulator of neoplastic behavior. Lab. Invest., 73: 157-160, 1995.
24. Böcking, A., Kiehn, J., and Heinzel-Wach, M. Combined histologic grading of prostatic carcinoma. Cancer (Phila.), 50: 288-294, 1982.
25. Hermanek, P., and Sobin, L. H. International Union against Cancer (UICC). Urological tumours: prostate. In: TNM Classification of Urological Tumours, 4th Ed., 2nd revision. New York: Springer-Verlag, p. 141, 1992.
26. Witsch-Prehm, P., Miehlke, R., and Kresse, H. Presence of small proteoglycan fragments in normal and arthritic human cartilage. Arthritis Rheum., 35: 1042-1052, 1992.
27. Braunewell, K-H., Martini, R., LeBaron, R., Kresse, H., Faissner, A., Schmitz, B., and Schachner, M. Up-regulation of a chondroitin sulphate epitope during regenerationation of mouse sciatic nerve: evidence that the immunoreactive molecules are related to the chondroitin sulphate proteoglycans decorin and versican. Eur. J. Neurosci., 7: 792-804, 1995.
28. Aherne, W. A., and Dunhill, M. S. Preparation of tissues: sampling. In: Morphometry, pp. 19-32. London: Edward Arnold, 1982.
29. Horsfall, D. J., Mayne, K., Skinner, J. M. S., Saccone, G. T. P., Marshall, V. R., and Tilley, W. D. Glycosaminoglycans of guinea pig prostate fibromuscular stroma: influence of estrogen and androgen on levels and location of chondroitin sulfate. Prostate, 25: 320-332, 1994.
30. Davis, C. E., Hyde, J. E., Bangdiwala, S. I., and Nelson, J. J. An example of dependencies among variables in a conditional logistic regression. In: S. H. Moolgavkar, and R. L Prentice, R. L. (eds.), Modern Statistical Methods in Chronic Disease Epidemiology, pp. 140-147. New York; John Wiley & Sons, Inc., 1986.
31. Catalona, W. J., and Smith, D. S. 5-Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J. Urol., 152: 1837-1842, 1994.
32. Walsh, P. C., Partin, A. W., and Epstein, J. I. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J. Urol., 152: 1831-1836, 1994.
33. Yeo, T. K., Brown, L., and Dvorak, H. F. Alterations in proteoglycan synthesis common to healing wounds and tumors. Am. J. Pathol., 138: 1437-1450, 1991.
34. Hauptmann, S., Zardi, L., Siri, A., Carnemolla, B., Borsi, L., Castellucci, M., Klosterhalfen, B., Hartung, P., Weis, J., Stocker, G., Haubeck, H-D., and Kirkpatrick, C. J. Extracellular matrix proteins in colorectal carcinomas: expression of tenascin and fibronectin isoforms. Lab. Invest., 73: 172-182, 1995.
35. Cohen, I. R., Murdoch, A. D., Naso, M. F., Marchetti, D., Berd, D., and Iozzo, R. V. Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res., 54: 5771-5774, 1994.
36. Inki, P., Larjava, H., Haapasalmi, K., Miettinen, H., Grenman, R., and Jalkanen, M. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes. Eur. J. Cell Biol., 63: 43-51, 1994.
37. Inki, P., Joensuu, H., Grenman, R., Klemi, P., and Jalkanen, M. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br. J. Cancer, 70: 319-323, 1994.
38. Inki, P., Stenback, F., Grenman, S., and Jalkanen, M. Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J. Pathol., 172: 349-355, 1994.
39. Simon, R., and Altman, D. G. Statistical aspects of prognostic factor studies in oncology. Br. J. Cancer, 69: 979-985, 1994.